Performant Healthcare sees FY25 revenue $131M-$135M, consensus $134.47M

“Despite macro factors impacting the broader payment integrity space, Performant delivered results within the originally guided range in 2024,” said Rohit Ramchandani, Chief Financial Officer. “Looking ahead to 2025, our focus is on delivering margin improvement through technology advancements and the natural scale of our business. We are introducing full-year 2025 revenue guidance to be in the range of $131M to $135M and full-year adjusted EBITDA guidance to be in the range of $8M to $9M, which nearly doubles our adjusted EBITDA year over year at the midpoint of guidance. The investments we have made and the results we achieved, both financial and organizational, continue to support our goal of achieving a 20% adjusted EBITDA margin target with the continued success of Project Turing and as implementations and revenue scale.”